Genesis Health Group Family Medicine Medicare: Not Enrolled in Medicare Practice Location: 301 N 4th Ave, Eldridge, IA 52748 Phone: 563-285-7232 Fax: 563-285-6742 |
News Archive
The brain under general anesthesia isn't "asleep" as surgery patients are often told - it is placed into a state that is a reversible coma, according to three neuroscientists who have published an extensive review of general anesthesia, sleep and coma, in the Dec. 30 issue of The New England Journal of Medicine.
Shire plc, the global specialty biopharmaceutical company, announced the divestiture of Daytrana (methylphenidate transdermal system) to Noven Pharmaceuticals, Inc. Daytrana, which is approved and marketed in the US for the treatment of Attention Deficit Hyperactivity Disorder in children and adolescents, will continue to be available for patients through Noven.
A team of Israeli and American researchers have found that silicon nanomaterials used for the localized delivery of chemotherapy drugs behave differently in cancerous tumors than they do in healthy tissues. The findings could help scientists better design such materials to facilitate the controlled and targeted release of the chemotherapy drugs to tumors.
Professor Jane Irvine, of York University's psychology department, is helping those heart patients who must use miniature implanted defibrillators to cope with the psychological stress caused by these devices. Implantable Cardioverter Defibrillators (ICDs) are programmed to electrically shock the heart in the event of a life threatening heart rhythm incident.
A recent study, currently available on the bioRxiv preprint server, indicates that a pair of dual-action monoclonal antibodies derived from an original 2003 SARS survivors could play an important role in the fight against coronavirus disease 2019 (COVID-19) due to their broadly neutralizing activity and the engagement of the immune system via effector function capabilities.
› Verified 9 days ago